ferric chloride has been researched along with Carotid Artery Narrowing in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coller, BS; Diacovo, TG; Filizola, M; Jiang, JK; Li, J; Nedelman, M; Negri, A; Shang, Y; Thomas, CJ; Vootukuri, S | 1 |
| Carvalho, LP; Chan, MY; Chen, W; Kang, TS; Kini, RM | 1 |
| Jin, SY; Sorvillo, N; Voorberg, J; Xiao, J; Xue, J; Zheng, XL | 1 |
| Dellas, C; Hasenfuss, G; Konstantinides, S; Loskutoff, DJ; Müller, K; Riedel, C; Schäfer, K; Thinnes, T | 1 |
| Dellas, C; Hasenfuss, G; Konstantinides, SV; Nitsche, M; Puls, M; Schäfer, K; Schroeter, MR; Weiss, E | 1 |
| Carmeliet, P; Fay, WP; Zhu, Y | 1 |
6 other study(ies) available for ferric chloride and Carotid Artery Narrowing
| Article | Year |
|---|---|
RUC-4: a novel αIIbβ3 antagonist for prehospital therapy of myocardial infarction.
Topics: Animals; Binding Sites; Blood Platelets; Carotid Stenosis; Chlorides; Disease Models, Animal; Emergency Medical Services; Ferric Compounds; Fibrinolytic Agents; Humans; Macaca fascicularis; Male; Mice; Mice, Transgenic; Molecular Dynamics Simulation; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Conformation; Pyrimidinones; Solubility; Thiadiazoles; Thrombosis; von Willebrand Factor | 2014 |
Fasxiator, a novel factor XIa inhibitor from snake venom, and its site-specific mutagenesis to improve potency and selectivity.
Topics: Amino Acid Sequence; Animals; Binding, Competitive; Blood Coagulation; Bungarotoxins; Bungarus; Carotid Stenosis; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Factor XIa; Ferric Compounds; Humans; Kinetics; Male; Mice, Inbred C57BL; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Partial Thromboplastin Time; Protein Conformation; Prothrombin Time; Recombinant Proteins; Structure-Activity Relationship; Thrombosis | 2015 |
Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis.
Topics: ADAM Proteins; ADAMTS13 Protein; Animals; Antibodies, Monoclonal; Carotid Stenosis; Chlorides; Disease Models, Animal; Dogs; Ferric Compounds; Half-Life; HEK293 Cells; Humans; Kinetics; Mesenteric Vascular Occlusion; Metalloendopeptidases; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Mutation; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Thrombosis; Transfection; von Willebrand Factor | 2011 |
Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.
Topics: Animals; Carotid Arteries; Carotid Stenosis; Cell Count; Chlorides; Disease Models, Animal; Ferric Compounds; Hemodynamics; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Plasminogen Activator; Tunica Intima; Tunica Media; Urokinase-Type Plasminogen Activator; Vascular Patency; Wound Healing | 2002 |
Plasminogen activator inhibitor-1 from bone marrow-derived cells suppresses neointimal formation after vascular injury in mice.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carotid Arteries; Carotid Artery Diseases; Carotid Stenosis; Cell Differentiation; Chlorides; DNA; Female; Ferric Compounds; Macrophages; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Plasminogen Activator Inhibitor 1; Thrombosis; Time Factors; Tunica Intima; Y Chromosome | 2006 |
Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.
Topics: Animals; Blood Platelets; Carotid Arteries; Carotid Stenosis; Chlorides; Ferric Compounds; Genetic Predisposition to Disease; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Plasminogen; Plasminogen Activator Inhibitor 1; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator | 1999 |